Works matching IS 13520504 AND DT 2018 AND VI 25 AND IP 5

Results: 22

Host genetic factors associated with hepatocellular carcinoma in patients with hepatitis C virus infection: A systematic review.

Published in:

Journal of Viral Hepatitis, 2018, v. 25, n. 5, p. 442, doi. 10.1111/jvh.12871

By:

Walker, A. J.;
Peacock, C. J.;
Pedergnana, V.;
STOP‐HCV Consortium;
Irving, W. L.

Publication type:

Article

The incidence and predictors of HBV relapse after cessation of tenofovir therapy in chronic hepatitis B patients.

Published in:

Journal of Viral Hepatitis, 2018, v. 25, n. 5, p. 590, doi. 10.1111/jvh.12851

By:

Chen, C.‐H.;
Hsu, Y.‐C.;
Lu, S.‐N.;
Hung, C.‐H.;
Wang, J.‐H.;
Lee, C.‐M.;
Hu, T.‐H.

Publication type:

Article

The presence of multiple NS5A RASs is associated with the outcome of sofosbuvir and ledipasvir therapy in NS5A inhibitor‐naïve patients with chronic HCV genotype 1b infection in a real‐world cohort.

Published in:

Journal of Viral Hepatitis, 2018, v. 25, n. 5, p. 535, doi. 10.1111/jvh.12850

By:

Kozuka, R.;
Hai, H.;
Motoyama, H.;
Hagihara, A.;
Fujii, H.;
Uchida‐Kobayashi, S.;
Morikawa, H.;
Enomoto, M.;
Murakami, Y.;
Kawada, N.;
Tamori, A.

Publication type:

Article

Prevalence of mixed genotype hepatitis C virus infections in the UK as determined by genotype‐specific PCR and deep sequencing.

Published in:

Journal of Viral Hepatitis, 2018, v. 25, n. 5, p. 524, doi. 10.1111/jvh.12849

By:

McNaughton, A. L.;
Sreenu, V. B.;
Wilkie, G.;
Gunson, R.;
Templeton, K.;
Leitch, E. C. M.

Publication type:

Article

Prophylactic antiviral therapy for the prevention of mother‐to‐child transmission of hepatitis B virus can be stopped at delivery.

Published in:

2018

By:

Zeng, Q.‐L.;
Xu, G.‐H.;
Wang, B.;
Li, Z.‐Q.;
Yu, Z.‐J.

Publication type:

Letter to the Editor

Assessing uncertainty in the burden of hepatitis C virus: Comparison of estimated disease burden and treatment costs in the UK.

Published in:

Journal of Viral Hepatitis, 2018, v. 25, n. 5, p. 514, doi. 10.1111/jvh.12847

By:

Gubay, F.;
Staunton, R.;
Metzig, C.;
Abubakar, I.;
White, P. J.

Publication type:

Article

Incidence and prevalence of hepatitis B in patients with diabetes mellitus in the UK: A population‐based cohort study using the UK Clinical Practice Research Datalink.

Published in:

Journal of Viral Hepatitis, 2018, v. 25, n. 5, p. 571, doi. 10.1111/jvh.12841

By:

Ferreira, G. L. C.;
Marano, C.;
De Moerlooze, L.;
Guignard, A.;
Feng, Y.;
El Hahi, Y.;
van Staa, T.

Publication type:

Article

The antiviral role of zinc and metallothioneins in hepatitis C infection.

Published in:

Journal of Viral Hepatitis, 2018, v. 25, n. 5, p. 491, doi. 10.1111/jvh.12845

By:

Read, S. A.;
Parnell, G.;
Booth, D.;
Douglas, M. W.;
George, J.;
Ahlenstiel, G.

Publication type:

Article

Establishing the cascade of care for hepatitis C in England—benchmarking to monitor impact of direct acting antivirals.

Published in:

Journal of Viral Hepatitis, 2018, v. 25, n. 5, p. 482, doi. 10.1111/jvh.12844

By:

Simmons, R.;
Ireland, G.;
Irving, W.;
Hickman, M.;
Sabin, C.;
Ijaz, S.;
Ramsay, M.;
Lattimore, S.;
Mandal, S.

Publication type:

Article

HCV‐positive lymphoma after sustained virological response with direct‐acting antiviral agents: The game is not over after HCV eradication.

Published in:

2018

By:

Rodríguez de Santiago, E.;
Velázquez Kennedy, K.;
García González, M.;
Gea Rodríguez, F.;
Téllez Villajos, L.;
Tavío Hernández, E.;
Albillos, A.

Publication type:

Letter to the Editor

Trends in hepatocellular carcinoma incidence and survival among people with hepatitis C: An international study.

Published in:

Journal of Viral Hepatitis, 2018, v. 25, n. 5, p. 473, doi. 10.1111/jvh.12837

By:

Alavi, M.;
Janjua, N. Z.;
Chong, M.;
Grebely, J.;
Aspinall, E. J.;
Innes, H.;
Valerio, H.;
Hajarizadeh, B.;
Hayes, P. C.;
Krajden, M.;
Amin, J.;
Law, M. G.;
George, J.;
Goldberg, D. J.;
Hutchinson, S. J.;
Dore, G. J.

Publication type:

Article

Estimating chronic hepatitis C prognosis using transient elastography‐based liver stiffness: A systematic review and meta‐analysis.

Published in:

Journal of Viral Hepatitis, 2018, v. 25, n. 5, p. 502, doi. 10.1111/jvh.12846

By:

Erman, A.;
Sathya, A.;
Nam, A.;
Bielecki, J. M.;
Feld, J. J.;
Thein, H‐H.;
Wong, W. W. L.;
Grootendorst, P.;
Krahn, M. D.

Publication type:

Article

Low incidence of hepatitis B virus reactivation and subsequent hepatitis in patients with chronic hepatitis C receiving direct‐acting antiviral therapy.

Published in:

Journal of Viral Hepatitis, 2018, v. 25, n. 5, p. 608, doi. 10.1111/jvh.12840

By:

Tamori, A.;
Abiru, S.;
Enomoto, H.;
Kioka, K.;
Korenaga, M.;
Tani, J.;
Enomoto, M.;
Sugiyama, M.;
Masaki, T.;
Kawada, N.;
Yatsuhashi, H.;
Nishiguchi, S.;
Mizokami, M.

Publication type:

Article

Temporal trend and risk determinants of hepatocellular carcinoma in chronic hepatitis B patients on entecavir or tenofovir.

Published in:

Journal of Viral Hepatitis, 2018, v. 25, n. 5, p. 543, doi. 10.1111/jvh.12832

By:

Hsu, Yao‐Chun;
Ho, Hsiu‐J.;
Lee, Teng‐Yu;
Huang, Yen‐Tsung;
Wu, Ming‐Shiang;
Lin, Jaw‐Town;
Wu, Chun‐Ying;
El‐Serag, Hashem B.

Publication type:

Article

Efficacy and safety of 12 weeks of elbasvir ± grazoprevir ± ribavirin in participants with hepatitis C virus genotype 2, 4, 5 or 6 infection: The C‐SCAPE study.

Published in:

Journal of Viral Hepatitis, 2018, v. 25, n. 5, p. 457, doi. 10.1111/jvh.12801

By:

Brown, A.;
Hézode, C.;
Zuckerman, E.;
Foster, G. R.;
Zekry, A.;
Roberts, S. K.;
Lahser, F.;
Durkan, C.;
Badshah, C.;
Zhang, B.;
Robertson, M.;
Wahl, J.;
Barr, E.;
Haber, B.;
the C‐SCAPE Study Investigators

Publication type:

Article

Comparative evaluation of GPR versus APRI and FIB‐4 in predicting different levels of liver fibrosis of chronic hepatitis B.

Published in:

Journal of Viral Hepatitis, 2018, v. 25, n. 5, p. 581, doi. 10.1111/jvh.12842

By:

Liu, D.‐P.;
Lu, W.;
Zhang, Z.‐Q.;
Wang, Y.‐B.;
Ding, R.‐R.;
Zhou, X.‐L.;
Huang, D.;
Li, X.‐F.

Publication type:

Article

IFN‐free therapy is associated with restoration of type I IFN response in HIV‐1 patients with acute HCV infection who achieve SVR.

Published in:

Journal of Viral Hepatitis, 2018, v. 25, n. 5, p. 465, doi. 10.1111/jvh.12836

By:

Carlton‐Smith, C.;
Holmes, J. A.;
Naggie, S.;
Lidofsky, A.;
Lauer, G. M.;
Kim, A. Y.;
Chung, R. T.;
of the ACTG A5327 study group

Publication type:

Article

Improved performance of quantitative collagen parameters versus standard histology in longitudinal assessment of nonadvanced liver fibrosis for chronic hepatitis B.

Published in:

Journal of Viral Hepatitis, 2018, v. 25, n. 5, p. 598, doi. 10.1111/jvh.12835

By:

Wang, Y.;
Liang, X.;
Yang, J.;
Wang, H.;
Tan, D.;
Chen, S.;
Cheng, J.;
Chen, Y.;
Sun, J.;
Rong, F.;
Yang, W.;
Liu, H.;
Liu, Z.;
Zheng, Y.;
Liang, J.;
Li, S.;
Hou, J.

Publication type:

Article

Knowledge regarding hepatitis B mother‐to‐child transmission among healthcare workers in South China.

Published in:

Journal of Viral Hepatitis, 2018, v. 25, n. 5, p. 561, doi. 10.1111/jvh.12839

By:

Chen, Y.;
Xie, C.;
Zhang, Y.;
Li, Y.;
Ehrhardt, S.;
Thio, C. L.;
Nelson, K. E.;
Lin, C.‐S.

Publication type:

Article

Delayed viral suppression during antiviral therapy is associated with increased hepatocellular carcinoma rates in HBeAg‐positive high viral load chronic hepatitis B.

Published in:

Journal of Viral Hepatitis, 2018, v. 25, n. 5, p. 552, doi. 10.1111/jvh.12838

By:

Nam, J. Y.;
Chang, Y.;
Cho, H.;
Kang, S. H.;
Cho, Y. Y.;
Cho, E. J.;
Lee, J.‐H.;
Yu, S. J.;
Yoon, J.‐H.;
Kim, Y. J.

Publication type:

Article

Issue Information.

Published in:: Journal of Viral Hepatitis, 2018, v. 25, n. 5, p. 439, doi. 10.1111/jvh.12774
Publication type:: Article

Cover Image.

Published in:

Journal of Viral Hepatitis, 2018, v. 25, n. 5, p. i, doi. 10.1111/jvh.12602

By:

Read, S. A.;
Parnell, G.;
Booth, D.;
Douglas, M. W.;
George, J.;
Ahlenstiel, G.

Publication type:

Article